Bando K, Onda M, Miyashita M, Takahashi Y, Takita M, Matsutani T, Okawa K, Sasajima K, Ujihara Y, Takubo K, Yamashita K
First Dept. of Surgery, Nippon Medical School.
Gan To Kagaku Ryoho. 1998 May;25(6):915-8.
A 67-year-old man was diagnosed as having a type 3 advanced esophageal carcinoma by barium swallow and endoscopy. Biopsy specimens showed well-differentiated squamous cell carcinoma with positive immunostaining for p53, C-erb B-2 and negative for bcl-2. Two courses of chemotherapy using 5-FU, leucovorin and CDDP were performed before operation. Because no cancer cells were present in the surgical specimens, the effect was evaluated as grade 3. This neoadjuvant chemotherapy may be effective for esophageal carcinoma with a possible apoptosis mechanism.
一名67岁男性经钡餐造影和内镜检查被诊断为3期进展期食管癌。活检标本显示为高分化鳞状细胞癌,p53、C-erb B-2免疫染色阳性,bcl-2免疫染色阴性。术前进行了两个疗程的化疗,使用5-氟尿嘧啶、亚叶酸钙和顺铂。由于手术标本中未发现癌细胞,疗效评估为3级。这种新辅助化疗可能对具有可能凋亡机制的食管癌有效。